Skip to main content
Premium Trial:

Request an Annual Quote

German Lab Network to Use Bruker Biotyper

NEW YORK (GenomeWeb News) – Bruker Daltonics will provide its MALDI Biotyper systems to more than 30 European clinical labs through an agreement with the Limbach laboratory network, Bruker said today.

Bruker said that the exclusive agreement covers orders for the Biotyper systems for labs in Ravensburg, Freiburg, and in Heidelberg. The company also said it reached an agreement with Limbach to jointly introduce the Biotyper in Poland through Limbach's labs in Warsaw and in Gdansk, and in other labs in Germany.

Limbach's Heidelberg lab installed a Biotyper system in 2007, and since then it has been installed at clinical microbiology centers in Heidelberg, Koblenz, Hamburg, Karlsruhe, Singen, Magdeburg, and Nordhorn, the company said.

The Bruker system uses proteomic fingerprinting for molecular identification, environmental and pharmaceutical analysis, taxonomical research, food and consumer product processing, quality control, and marine microbiology.

Financial terms of the agreement were not released.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.